辰欣药业：股东石家庄四药有限公司计划减持公司股份不超过约453万股

Group 1 - The core point of the news is that Shijiazhuang Four Pharmaceutical Co., Ltd. plans to reduce its stake in Chenxin Pharmaceutical, which currently holds approximately 27.66 million shares, accounting for 6.11% of the total share capital [1] - Shijiazhuang Four Pharmaceutical intends to implement the reduction plan within three months after a 15 trading day period from the announcement date, with a maximum reduction of approximately 4.53 million shares, not exceeding 1% of the total share capital [1] - The revenue composition of Chenxin Pharmaceutical for the year 2024 is projected to be 99.75% from the pharmaceutical manufacturing industry and 0.25% from other businesses [1] Group 2 - As of the report, Chenxin Pharmaceutical has a market capitalization of 11.5 billion yuan [2]